Molenaar W M, Oosterhuis J W, Kamps W A
Hum Pathol. 1984 Oct;15(10):973-9. doi: 10.1016/s0046-8177(84)80127-6.
The effectiveness of polychemotherapy in young patients with rhabdomyosarcomas has been well established. The morphologic alterations in the tumor tissue, however, have not been widely reported. Therefore, in a group of 15 patients from 1 to 24 years of age, specimens of tumor tissue obtained before and after polychemotherapeutic treatment were compared. No morphologic changes, other than fibrosis and necrosis, occurred in patients who initially had virtually undifferentiated tumors. When moderately or well-differentiated areas were present in the initial specimens, these areas showed proportionate increases in the follow-up specimens. Moreover, the cellular characteristics of round rhabdomyoblasts and strap cells with or without cross-striations became more distinct after treatment. However, cell types that were not present in the initial specimens were never found in follow-up specimens. It was concluded that the major role of polychemotherapy is the selective destruction of undifferentiated tumor cells; further differentiated cells are stimulated either directly or indirectly to reach their maximal inherent differentiation levels, but it does not appear that transitions from one cell type to the other occur.
多药化疗在年轻横纹肌肉瘤患者中的有效性已得到充分证实。然而,肿瘤组织的形态学改变尚未得到广泛报道。因此,对一组15名年龄在1至24岁的患者,比较了多药化疗前后获取的肿瘤组织标本。最初几乎未分化的肿瘤患者,除纤维化和坏死外,未出现形态学变化。当初始标本中存在中度或高度分化区域时,这些区域在随访标本中显示出相应增加。此外,有或无横纹的圆形横纹肌母细胞和带状细胞的细胞特征在治疗后变得更加明显。然而,初始标本中不存在的细胞类型在随访标本中从未发现。得出的结论是,多药化疗的主要作用是选择性破坏未分化的肿瘤细胞;进一步分化的细胞直接或间接受到刺激,以达到其最大固有分化水平,但似乎不会发生从一种细胞类型向另一种细胞类型的转变。